CoChat

Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression

Open access
Bellet, Marina M., Vawter, Marquis P., Bunney, Blynn G., Bunney, William E., Sassone-Corsi, Paolo · 2011 · PLoS ONE

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

Major mood disorders have been linked to abnormalities in circadian rhythms, leading to disturbances in sleep, mood, temperature, and hormonal levels. We provide evidence that ketamine, a drug with rapid antidepressant effects, influences the function of the circadian molecular machinery. Ketamine modulates CLOCK:BMAL1-mediated transcriptional activation when these regulators are ectopically expressed in NG108-15 neuronal cells. Inhibition occurs in a dose-dependent manner and is attenuated after treatment with the GSK3β antagonist SB21673. We analyzed the effect of ketamine on circadian gene expression and observed a dose-dependent reduction in the amplitude of circadian transcription of the Bmal1, Per2, and Cry1 genes. Finally, chromatin-immunoprecipitation analyses revealed that ketamine altered the recruitment of the CLOCK:BMAL1 complex on circadian promoters in a time-dependent manner. Our results reveal a yet unsuspected molecular mode of action of ketamine and thereby may suggest possible pharmacological antidepressant strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0023982

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Ketamine treatment represses CLOCK:BMAL1 transactivation potential on the mPer1 gene promoter. (A) Effect of ketamine on CLOCK:BMAL1 dependent transcription. Vectors expressing CLOCK:BMAL1 (C:B, 25 ng each) were cotransfected with a construct containing the mPer1 promoter (pGL3-mPer1-Luc, 50 ng) in NG108-15 cells. The total DNA amount was kept constant by adding carrier plasmid DNA. After 6 hs of transfection, cells were treated with increasing amounts of ketamine (K, 18 h, + as 10 mM and ++ as 1 mM). After normalization for transfection efficiency using β-galactosidase activity, reporter gene activities were expressed relative to those of a control transfected only with non-expressing plasmids. All the values are the mean +/− SD (n = 3); (**) p<0.01. (B) The E box promoter element mediates ketamine repression of CLOCK:BMAL1. Experimental conditions were as in A except that reporter constructs containing three copies of the E box consensus sequence (pGL3 promoter (E box) X3 LUC) or its mutated form (pGL3 promoter (Emut) X3 LUC) were used. All values are the mean +/− SD (n = 3); (*) p<0.05, (**) p<0.01. (C) Ketamine repression of CLOCK:BMAL1 involves activation of GSK3β. Experimental conditions were as in B except that the kinase inhibitors UO126 (ERK kinase inhibitor), SB216763 (GSK3β kinase inhibitor) and GF109203 (PKC kinase inhibitor) were applied to cells together with ketamine treatment (K, ++ as 1 mM). % of repression of CLOCK:BMAL1 transactivation with ketamine alone or ketamine with different kinase inhibitors is shown. All values are the mean +/− SD (n = 3); (*) p<0.05.
Figure 1 Ketamine treatment represses CLOCK:BMAL1 transactivation potential on the mPer1 gene promoter. (A) Effect of ketamine on CLOCK:BMAL1 dependent transcription. Vectors expressing CLOCK:BMAL1 (C:B, 25 ng each) were cotransfected with a construct containing the mPer1 promoter (pGL3-mPer1-Luc, 50 ng) in NG108-15 cells. The total DNA amount was kept constant by adding carrier plasmid DNA. After 6 hs of transfection, cells were treated with increasing amounts of ketamine (K, 18 h, + as 10 mM and ++ as 1 mM). After normalization for transfection efficiency using β-galactosidase activity, reporter gene activities were expressed relative to those of a control transfected only with non-expressing plasmids. All the values are the mean +/− SD (n = 3); (**) p<0.01. (B) The E box promoter element mediates ketamine repression of CLOCK:BMAL1. Experimental conditions were as in A except that reporter constructs containing three copies of the E box consensus sequence (pGL3 promoter (E box) X3 LUC) or its mutated form (pGL3 promoter (Emut) X3 LUC) were used. All values are the mean +/− SD (n = 3); (*) p<0.05, (**) p<0.01. (C) Ketamine repression of CLOCK:BMAL1 involves activation of GSK3β. Experimental conditions were as in B except that the kinase inhibitors UO126 (ERK kinase inhibitor), SB216763 (GSK3β kinase inhibitor) and GF109203 (PKC kinase inhibitor) were applied to cells together with ketamine treatment (K, ++ as 1 mM). % of repression of CLOCK:BMAL1 transactivation with ketamine alone or ketamine with different kinase inhibitors is shown. All values are the mean +/− SD (n = 3); (*) p<0.05.CC BY · PubMed Central
Figure 2 Altered circadian expression of clock genes and CCGs after ketamine treatment. Per2, Dbp, Bmal1 and Cry1 mRNA expression profiles in WT MEFs, untreated or treated for 1 h with ketamine (10 mM and 1 mM) at circadian times CT11–12, CT17–18, CT 23–24, CT29–30 after serum shock, were analyzed by quantitative PCR. The values are relative to those of 18S mRNA levels at each CT (circadian time). Time 12 (CT12) value in untreated cells was set to 1. All values are the mean +/− SD (n = 3); (*) p<0.05, (**) p<0.01, (***) p<0.001.
Figure 2 Altered circadian expression of clock genes and CCGs after ketamine treatment. Per2, Dbp, Bmal1 and Cry1 mRNA expression profiles in WT MEFs, untreated or treated for 1 h with ketamine (10 mM and 1 mM) at circadian times CT11–12, CT17–18, CT 23–24, CT29–30 after serum shock, were analyzed by quantitative PCR. The values are relative to those of 18S mRNA levels at each CT (circadian time). Time 12 (CT12) value in untreated cells was set to 1. All values are the mean +/− SD (n = 3); (*) p<0.05, (**) p<0.01, (***) p<0.001.CC BY · PubMed Central
Figure 3 Altered CLOCK and BMAL1 circadian recruitment to CCGs promoter after ketamine treatment. Cross-linked cell extracts were isolated at the indicated time points after serum shock from MEFs, not treated or treated with ketamine (1 mM) for 1 h before each time point. The samples were subjected to ChIP assay with anti-CLOCK, anti-BMAL1 and anti-IgG, and analyzed by quantitative PCR with primers for Dbp promoter. Control IgG (ctr) and Dbp 3′UTR (3′ region of Dbp promoter) primers were used as controls for immunoprecipitation and PCR, respectively. All the values are the mean +/− SD (n = 3); (*) p<0.05, (***) p<0.001.
Figure 3 Altered CLOCK and BMAL1 circadian recruitment to CCGs promoter after ketamine treatment. Cross-linked cell extracts were isolated at the indicated time points after serum shock from MEFs, not treated or treated with ketamine (1 mM) for 1 h before each time point. The samples were subjected to ChIP assay with anti-CLOCK, anti-BMAL1 and anti-IgG, and analyzed by quantitative PCR with primers for Dbp promoter. Control IgG (ctr) and Dbp 3′UTR (3′ region of Dbp promoter) primers were used as controls for immunoprecipitation and PCR, respectively. All the values are the mean +/− SD (n = 3); (*) p<0.05, (***) p<0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 70

Metadata

Authors
Bellet, M. M., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P.
Affiliations
University of California, Irvine (US)
Corresponding author
Bunney, William E.
Venue
PLoS ONE
Published
2011-08-24
Volume
6
Issue
8
Pages
e23982
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2171839813
Cited by
70
References
76
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 6 · 2021: 9 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 2 · 2012: 3
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • Della Martin Foundation
  • National Institutes of Health (AG033888)
  • National Institute on Aging (R21AG033888)
  • National Institute of Mental Health (R01MH085801)
  • National Institute of General Medical Sciences (R01GM081634)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Keywords
ketamine, circadian clock, Clock/BMAL1, circadian gene expression, GSK3β, antidepressant mechanism, mood disorders, circadian rhythm, Per2, CRY1, Bmal1, transcriptional repression, chromatin recruitment, NG108-15 cells
MeSH terms
Animals, Gene Expression Regulation, Ketamine, Poly(ADP-ribose) Polymerases, Species Specificity, Excitatory Amino Acid Antagonists, Mice, Circadian Rhythm Signaling Peptides and Proteins, CLOCK Proteins, Cryptochromes, Period Circadian Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression. https://app.cochat.ai/papers/10.1371/journal.pone.0023982
The paper
Bellet, M. M., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P. (2011). Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression. PLoS ONE. https://doi.org/10.1371/journal.pone.0023982

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.